pharmacy benefit managers

Updated at 8 p.m. ET

CVS is preparing to buy the health insurance giant Aetna for $69 billion, the companies say.

Flurry of Federal and State Probes Target Insulin Drugmakers and Pharma Middlemen

Nov 4, 2017

With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industry’s financial middlemen, seeking answers about their business relationships and the soaring price of diabetes drugs.

Jill Sheridan / Indiana Public Broadcasting

More than half a million Hoosiers have been diagnosed with diabetes, and many of them rely on insulin to live healthy lives. But patients say the skyrocketing price of the medicine —which more than doubled from 2002 to 2013 — is squeezing them to the point of outrage.